2
Clinical Trials associated with Tetanus toxoids adsorbed( Sanofi) / CompletedNot Applicable Post-licensure Safety Surveillance Study of Routine Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel®)
To further characterize the vaccine safety profile and to identify any signals of potentially vaccine-related adverse events (AEs) not detected during pre-licensure studies.
Phase 1 Trial of a Monoclonal Antibody to OX40 in Patients With Advanced Cancer.
This study is designed to determine the safety and highest tolerated dose of anti-OX40 in patients with advanced cancer.
100 Clinical Results associated with Tetanus toxoids adsorbed( Sanofi)
100 Translational Medicine associated with Tetanus toxoids adsorbed( Sanofi)
100 Patents (Medical) associated with Tetanus toxoids adsorbed( Sanofi)
100 Deals associated with Tetanus toxoids adsorbed( Sanofi)